Centricity Vision Introduces New Name and Leadership Team

The New Name Captures the Company’s Core Expertise and Long-Term Commitment to Bringing an Expanded Line of Refractive Surgery Products to Surgeons and Patients Worldwide

Centricity Vision, Inc., formerly known as Mynosys Cellular Devices, Inc., a global ophthalmic technology company dedicated to delivering products that help surgeons optimize outcomes in refractive surgery, today announced a new executive leadership team, along with a new company name.

“Centricity Vision” reflects the company’s core competency, embodied by its ZEPTO® Precision Cataract Surgery Platform, in creating precise, consistent, visual axis-centered capsulotomies. The new name also conveys the company’s evolution as it looks to expand its vision care product pipeline beyond ZEPTO® while remaining committed to improving cataract surgery outcomes for surgeons and their patients.

In addition to Rob Thornhill’s recent appointment as Chief Executive Officer, new executive team members include Louis Bunn, Chief Financial Officer; Todd Pinkney, Vice President of Marketing; Kevin Pratt, Vice President of Sales; Dan Glazerman, Vice President of Research, Development and Manufacturing; and Nealen Hartman, Vice President of Regulatory Affairs and Quality Assurance. This seasoned team leverages extensive experience in the ophthalmology and medical device industries to drive technological innovation, product quality and commercial success.

The company’s ZEPTO® Platform enables precise, reproducible, circular, visual axis-centered capsulotomies that facilitate a 360-degree overlap of the IOL optic. Published studies demonstrate the ZEPTO® capsulotomy edge was two to four times stronger than manual CCC and femtosecond laser capsulotomy.1 ZEPTO® not only automates the anterior capsulotomy, but also enables precise visual axis centration.2

“We have evolved significantly as a company, and we think it’s time our name did too,” said Rob Thornhill, President and CEO of Centricity Vision. “Building on our commitment to assisting surgeons in delivering the best care to their patients, our vision for the future includes leveraging our ZEPTO® technology to create a suite of next-generation ophthalmic capsular management products. I’m grateful for the opportunity to work with our new management team to deliver high-quality systems to our customers and their patients.”

 

The ZEPTO® Precision Cataract Surgery Platform enables consistent, visual axis-centered, high-quality anterior capsulotomies during cataract surgery. ZEPTO® integrates seamlessly into the routine steps of cataract surgery without increasing operative time or space requirements. The ZEPTO® platform consists of a disposable handpiece and a small, inexpensive control console. The ZEPTO® precision pulse capsulotomy technology utilizes a proprietary energy control algorithm to deliver a four-millisecond energy pulse, in combination with calibrated suction, to produce highly accurate, reproducible and strong-edged capsulotomies. ZEPTO® performs equally as well in standard or difficult cases and is ideal for cataract patients choosing premium or non-premium lenses.

ZEPTO® is available directly through the company’s sales and practice support team in the United States, as well as through select distributors in Europe and Asia.

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.